secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOHNSON & JOHNSON (JNJ)
CIK:        0000200406
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0000200406-23-000059
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Thibaut Mongon leaving JNJ executive roles after Kenvue IPO; annual meeting results announced
--------------------------------------------------------------------------------

- Thibaut Mongon to step down as EVP, WW Chairman Consumer Health and Executive Committee member upon Kenvue IPO closing; remains Kenvue CEO.
- All 12 Johnson & Johnson director nominees elected at annual meeting; each received >1.68B votes in favor.
- Shareholders approved advisory say-on-pay (1.685B for, 123M against) and set frequency at 1 year until 2029.
- Ratification of PwC as independent auditor for FY2023 passed with 2.049B votes for, 119M against.
- Two shareholder proposals—Vaccine Pricing Report and Extended Patent Exclusivities Report—were rejected by wide margins.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/200406/000020040623000059/0000200406-23-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/200406/000020040623000059/jnj-20230427.htm
  HTML page:      https://secwatch.observer/filing/0000200406-23-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer